David Rubin is a Gastroenterologist in Chicago, Illinois. Rubin has been practicing medicine for over 29 years and is rated as an Elite expert by MediFind in the treatment of Crohn's Disease. He is also highly rated in 19 other conditions, according to our data. His top areas of expertise are Ulcerative Colitis, Colitis, Crohn's Disease, Endoscopy, and Colonoscopy. Rubin is currently accepting new patients.
Stephen Hanauer is a Gastroenterologist in Chicago, Illinois. Hanauer has been practicing medicine for over 50 years and is rated as an Elite expert by MediFind in the treatment of Crohn's Disease. He is also highly rated in 9 other conditions, according to our data. His top areas of expertise are Crohn's Disease, Ulcerative Colitis, Viral Gastroenteritis, Colonoscopy, and Ileostomy. Hanauer is currently accepting new patients.
Feza Remzi is a General Surgeon and a Colorectal Surgeon in New York, New York. Remzi has been practicing medicine for over 34 years and is rated as an Elite expert by MediFind in the treatment of Crohn's Disease. He is also highly rated in 22 other conditions, according to our data. His top areas of expertise are Crohn's Disease, Viral Gastroenteritis, Colitis, Ileostomy, and Endoscopy. Remzi is currently accepting new patients.
Summary: The purpose of Study D5271C00002 (Legacy #3150-303-008) is to permit participants in D5271C00001 (Legacy #3150-301-008) to receive open-label brazikumab in Study D5271C00002 (Legacy #3150-303-008). This will permit long-term observation of safety in these participants with brazikumab.
Background: Bacteria and other microorganisms that live in the intestines (the gut microbiome) play an important role in a person s health. The gut microbiome helps to regulate the immune system and control inflammation. Imbalances in the gut microbiome have been linked to illnesses such as inflammatory bowel disease (IBD). People diagnosed with IBD can have serious health problems. Researchers want to know m...